DNLI
Denali Therapeutics Inc
20.50$
-5.3%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 91.1% | 67.1% | 84.2% | 72.6% | 77.7% | 93.2% | 63.9% | 94.0% | 92.2% | 62.9% | 78.7% | |
| 83.8% | 14.7% | 44.9% | 11.7% | 14.4% | 31.6% | 20.9% | 14.9% | 11.0% | 12.7% | 17.9% | |
| 83.8% | 65.8% | 83.5% | 70.1% | 75.1% | 91.6% | 61.6% | 91.5% | 89.7% | 60.6% | 75.8% | |
| – | 0.2% | 0.1% | 1.3% | – | 0.4% | 0.1% | 0.6% | 0.3% | 0.2% | 0.2% | |
| – | – | -0.1% | -1.3% | – | – | – | -0.3% | 0.0% | – | – | |
| 8.6% | 5.6% | 3.1% | 3.8% | 14.6% | 2.5% | 5.0% | 5.1% | – | – | – | |
| 142.6% | 6.1% | 4.3% | 17.4% | 28.6% | 28.3% | 31.5% | 28.6% | 10.7% | 10.5% | 11.5% | |
| 9.5% | 3.4% | 2.9% | 5.0% | 8.2% | 4.5% | 26.9% | 24.9% | 6.8% | 7.4% | 8.6% | |
| – | – | – | 2.9% | 0.7% | 0.3% | 0.4% | 0.5% | 0.6% | 0.9% | 0.8% | |
| 4.7% | 0.7% | 0.6% | 0.3% | 0.5% | 0.1% | 0.3% | 0.2% | 0.8% | 0.8% | 0.3% | |
| -42.6% | 93.9% | 95.7% | 82.6% | 71.4% | 71.7% | 68.5% | 71.4% | 89.3% | 89.5% | 88.5% | |
| -46.0% | -38.2% | -39.4% | -34.4% | -76.9% | -22.1% | -45.9% | -66.5% | -96.7% | -112.0% | -179.2% | |
| 8.2% | 2.4% | 3.1% | 14.0% | 17.3% | 7.0% | 8.7% | 8.6% | 11.9% | 12.0% | 15.3% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.